טוען...
Prediction from Creatinine Clearance of Thrombocytopenia and Recommended Dose in Patients Receiving (Glycolato‐O, O′)‐diammine Platinum (II) (NSC 375101D)
Thrombocytopenia is the most serious dose‐limiting toxicity of (glycolato‐O, O′)‐diammine platinum (II) (254‐S; NSC 375101D), one of the new platinum analogues. A total of 38 patients treated with 100 mg of 254‐S per m(2) in a clinical phase II study were retrospectively analyzed to determine the fa...
שמור ב:
| הוצא לאור ב: | Jpn J Cancer Res |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Blackwell Publishing Ltd
1990
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5963895/ https://ncbi.nlm.nih.gov/pubmed/2110134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.1990.tb02548.x |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|